At the ESMO 2012 Congress new findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released. The Congress is that of the European Society for Medical Oncology in Vienna. Venous thromboembolism causes symptoms in about 3 to 4% of cancer patients whose chemotherapy drugs are delivered via a central venous catheter, comments Dr. Fausto Roila, from Medical Oncology Department, Terni, Italy, Chair of the ...Thursday, 4 October 2012
The Challenges of Managing Blood Clotting in Cancer Patients Highlighted By New Findings
At the ESMO 2012 Congress new findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released. The Congress is that of the European Society for Medical Oncology in Vienna. Venous thromboembolism causes symptoms in about 3 to 4% of cancer patients whose chemotherapy drugs are delivered via a central venous catheter, comments Dr. Fausto Roila, from Medical Oncology Department, Terni, Italy, Chair of the ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment